It is assumed that genetic factors play a role in the common forms of migraine due to its observed aggregation in families (1-3), higher concordance in monozygotic compared with dizygotic twins (4) and successful identification of migraine genes for familial hemiplegic migraine (5, 6) . The genetic determinants of the common forms of migraine are likely to be complex and significantly modified by environmental influences (5) , and thus a challenge to identify and replicate in multiple populations.
The C677T variant of the methylenetetrahydrofolate reductase enzyme (MTHFR C677T) has been the most extensively studied candidate gene for a common migraine type. The MTHFR enzyme is a key enzyme in the folate metabolic pathway. Homozygotes for the common MTHFR C677T variant have moderately elevated homocysteine if dietary intake of folic acid is low to moderate (7). Elevated homocysteine is associated with disruption of endothelial function and modestly increased risk of cardiovascular disease (8, 9) . It is biologically plausible that elevated homocysteine is related to the initiation of the migraine aura and-furthermay explain to some extent the well-known relationship between migraine with aura and cardiovascular disease (8, 10) .
In this issue of Cephalalgia, Rubino et al. (11) pooled the results from eight gene-association studies measuring the relationship between MTHFR C677T genotype and migraine with or without aura. The studied populations were (primarily) unrelated patient samples and controls from Australia, Finland, Germany, Japan, Spain, the Netherlands and Turkey. The pooled estimate of effect indicated a significant, but modest (odds ratio ª 1.5) risk of migraine with aura associated with MTHFR C677T genotype using both fixed and random effect models. The pooled association was not significant for migraine overall (i.e. migraine with or without aura). (One additional clinical study published after this meta-analysis was consistent with the pooled measure of effect (12) . Notably, a recent analysis from the Women's Health Study found a lower prevalence of the TT genotype in women with self-reported migraine with aura compared with controls. Women with prevalent cardiovascular disease were excluded from this study (13) .)
Given both the modest pooled estimate of effect and evidence of heterogeneity, as noted by the authors, it may yet turn out that this most promising candidate gene is a false lead. However, lack of replication may also be related to a true small effect, population differences in folic acid intake (through diet, use of supplements, and mandated food fortification (14) ), and population variability in the prevalence of effect-modifying polymorphisms (15, 16) .
If elevated homocysteine is the mechanism by which MTHFR C677T increases risk of migraine with aura, how likely is it that homocysteinelowering therapy would be effective as a preventive treatment for migraine? Clinical trials to date of folic acid supplementation to prevent incident ischaemic cardiovascular disease have been mostly negative (17), although, again, studies may have been underpowered to detect what would probably be a small effect (18) (19) (20) . Pilot studies of homocysteine-lowering therapy for migraine are most likely to be informative if based on migraineurs with aura and with enough men to detect a sex-specific effect (21) . 
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